Understanding Value Stocks
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Pfizer (NYSE:PFE) – P/E: 9.24
- Baudax Bio (NASDAQ:BXRX) – P/E: 0.02
- Palisade Bio (NASDAQ:PALI) – P/E: 0.18
- Selecta Biosciences (NASDAQ:SELB) – P/E: 5.19
- ITeos Therapeutics (NASDAQ:ITOS) – P/E: 3.03
Pfizer has reported Q3 earnings per share at $1.78, which has decreased by 12.75% compared to Q2, which was 2.04. Most recently, the company reported a dividend yield of 3.64%, which has increased by 0.38% from last quarter’s yield of 3.26%.
Baudax Bio has reported Q3 earnings per share at $-0.39, which has increased by 43.48% compared to Q2, which was -0.69. Palisade Bio’s earnings per share for Q3 sits at $-0.08, whereas in Q2, they were at -0.12. Selecta Biosciences’s earnings per share for Q3 sits at $-0.05, whereas in Q2, they were at 0.06. ITeos Therapeutics has reported Q3 earnings per share at $0.03, which has decreased by 80.0% compared to Q2, which was 0.15.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
